North Coast Biologics is a an emerging Seattle biotechnology company that is committed to the discovery of therapeutic, diagnostic, and target-validating monoclonal antibodies. Using an antibody generation system that is vastly more efficient and rapid than standards of practice coupled with a humble approach that harkens back to the early days of our industry, North Coast intends to dramatically reduce the cost and time of high value antibody discovery to empower existing and emerging companies that wish to develop them.